References
- M. Alpsten, C. Bogentoft, G. Ekenved, L. Solvell. (1982). Gastric emptying and absorption of acetylsalicylic acid administered as entericcoated microgranules Eur. J. Clin. Pharmacol. 22:57–61.
- C. Bogentoft, I. Carlsson, G. Ekenved, A. Magnusson. (1978). Influence of food on the absorption of acetylsalicylic acid from entericcoated dosage forms Eur. J. Clin. Pharmacol. 14:351–355.
- W. Chambliss, D. Chambliss, R. Cleary, A. Jones, E. Harland, A. Kibbe. (1984). Development and evaluation of entericcoated penicillamine tablets J. Pharm. Sci. 73:1215–1219.
- B. Charles, P. Ravenscroft, P. Renshaw. (1982). Comparative pharmacokinetics of propranolol and 4hydroxypropranolol using conventional and longacting propranolol J. Pharm. Pharmacol. 34:403–404.
- C. Code, J. Marlett. (1975). The interdigestive myoelectric complex of the stomach and small bowel of dogs J. Physiol. 246:289–309.
- S. Davis, J. Hardy, M. Taylor, D. Whalley, C. Wilson. (1984). The effect of food on the gastrointestinal transit of pellets and an osmotic device osmet Int. J. Pharm. 21:331–340.
- S. Davis, R. Kholsa, C. Wilson, N. Washington. (1987). Gastrointestinal transit of a controlledrelease pellet formulation of tiaprofenic acid and the effect of food Int. J. Pharm. 35:253–258.
- S. Davis, J. Hardy, J. Fara. (1986). Transit of pharmaceutical dosage forms through the small intestine Gut 27:886–892.
- J. Fara, R. Myrback, D. Swanson. (1985). Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites Br. J. Clin. Pharmac. 19:91S–95S.
- M. Garty, A. Hurwitz. (1980). Effect of cimetidine on gastrointestinal absorption of tetracycline Clin. Pharmacol. Ther. 28:203–207.
- J. Hardy, C. Wilson, E. Wood. (1985). Drug delivery to the proximal colon J. Pharm. Pharmacol. 37:874–877.
- T. Itoh, T. Higuchi, C. Gardner, L. Caldwell. (1986). Effect of particle size and food on gastric residence time of nondistintegrating solids in beagle dog J. Pharm. Pharmacol. 38:801–806.
- J. Liaw, A. Rubinstein, J. Robinson. (1990). Bioavailability study of Theodur tablets in the fasted cannulated dog Int. J. Pharm. 59:104–114.
- J. McAnish, N. Baber, B. Holmes, J. Young, S. Ellis. (1981). Bioavailability of sustained release propranolol formulations Biopharm. Drug Dispos. 2:39–48.
- N. Nishimura, K. Sasahara, M. Arai, T. Nitani, Y. Ikegami, T. Morioka, E. Nakajima. (1984). Dosage form design for improvement of bioavailability of levodopa VI: Formulation of effervescent entericcoated tablets J. Pharm. Sci. 73:942–946.
- H. Ogata, N. Aoyagi, N. Kaniwa, A. Ejima, K. Suzuki, T. Ishioka, M. Morishita, K. Ohta, Y. Takagishi, Y. Doi, T. Ogura. (1984). Development and evaluation of a new peroral test agent GAtest for assessment of gastric acidity J. Pharm. Dyn. 7:656–664.
- C. Regardh, L. Ek, K. Hoffman. (1979). Plasma levels and blocking effect of hydroxymetoprololmetabolite of metoprololin the dog J. Pharmcokin. Biopharm. 7:471–479.
- R. Reed, H. Schwartz. (1984). Lack of influence of an intensive antacid regimen on theophylline bioavailability J. Pharmacokin. Biopharm. 12:315–331.
- S. Ueda, T. Hata, S. Asakura, H. Yamaguchi, M. Kotani, Y. Ueda. (1993a). Development of a novel drug delivery system, TimeControlled Explosion System TES. I. Concept and design J. Drug Targeting :
- S. Ueda, H. Yamaguchi, M. Kotani, S. Kimura, Y. Tokunaga, A. Kagayama, T. Hata. (1993b). Development of a novel drug delivery system, TimeControlled Explosion System TES. II. Design of multiparticulate TES and in vitro drug release properties Chem. Pharm. Bull. :
- S. Ueda, R. Ibuki, S. Kimura, S. Murata, T. Takahashi, Y. Tokunaga, T. Hata. (1993c). Development of a novel drug delivery system, TimeControlled Explosion System TES. III. Relationship between lag time and membrane thickness Chem. Pharm. Bull. :
- J. Wagner. (1985). Propranolol: Pooled michaelismenten parameters and the effect of input rate on bioavailability Clin. Pharmacol. Ther. 37:481–487.